121 related articles for article (PubMed ID: 12139731)
21. Acute lymphoblastic leukemia: optimizing treatment strategies in children.
Vora A
Paediatr Drugs; 2002; 4(6):405-16. PubMed ID: 12038876
[TBL] [Abstract][Full Text] [Related]
22. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
Chessells JM; Durrant J; Hardy RM; Richards S
J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
[TBL] [Abstract][Full Text] [Related]
23. Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
Durrant IJ; Richards SM
Br J Haematol; 1993 Sep; 85(1):84-92. PubMed ID: 8251413
[TBL] [Abstract][Full Text] [Related]
24. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
Lawson SE; Harrison G; Richards S; Oakhill A; Stevens R; Eden OB; Darbyshire PJ
Br J Haematol; 2000 Mar; 108(3):531-43. PubMed ID: 10759711
[TBL] [Abstract][Full Text] [Related]
25. Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.
Chessells JM; Harrison G; Richards SM; Bailey CC; Hill FG; Gibson BE; Hann IM
Arch Dis Child; 2001 Oct; 85(4):321-5. PubMed ID: 11567943
[TBL] [Abstract][Full Text] [Related]
26. The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.
Mitchell C; Payne J; Wade R; Vora A; Kinsey S; Richards S; Eden T
Br J Haematol; 2009 Aug; 146(4):424-36. PubMed ID: 19549269
[TBL] [Abstract][Full Text] [Related]
27. Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003.
Bartram J; Wade R; Vora A; Hancock J; Mitchell C; Kinsey S; Steward C; Moppett J; Goulden N
Arch Dis Child; 2016 May; 101(5):449-54. PubMed ID: 26865705
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003.
Hough R; Rowntree C; Goulden N; Mitchell C; Moorman A; Wade R; Vora A
Br J Haematol; 2016 Feb; 172(3):439-51. PubMed ID: 26683485
[TBL] [Abstract][Full Text] [Related]
29. Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
Chessells JM; Eden OB; Bailey CC; Lilleyman JS; Richards SM
Leukemia; 1994 Aug; 8(8):1275-9. PubMed ID: 8057661
[TBL] [Abstract][Full Text] [Related]
30. Improved outcome of acute lymphoblastic leukaemia treated by delayed intensification in Hong Kong children: HKALL97 study.
Li CK; Chik KW; Ha SY; Lee AC; Yuen HL; Ling SC; Lee V; Chan GC; Shing MM; Chan LC; Ng MH
Hong Kong Med J; 2006 Feb; 12(1):33-9. PubMed ID: 16495587
[TBL] [Abstract][Full Text] [Related]
31. Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in north India.
Trehan A; Bansal D; Varma N; Vora A
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27762058
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.
Eden OB; Harrison G; Richards S; Lilleyman JS; Bailey CC; Chessells JM; Hann IM; Hill FG; Gibson BE
Leukemia; 2000 Dec; 14(12):2307-20. PubMed ID: 11187922
[TBL] [Abstract][Full Text] [Related]
33. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
34. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.
Enshaei A; Vora A; Harrison CJ; Moppett J; Moorman AV
Lancet Haematol; 2021 Nov; 8(11):e828-e839. PubMed ID: 34715050
[TBL] [Abstract][Full Text] [Related]
35. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
[TBL] [Abstract][Full Text] [Related]
37. The Medical Research Council trials in adult acute lymphocytic leukemia.
Durrant IJ; Richards SM; Prentice HG; Goldstone AH
Hematol Oncol Clin North Am; 2000 Dec; 14(6):1327-52. PubMed ID: 11147226
[TBL] [Abstract][Full Text] [Related]
38. Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia.
Hough R; Chetwood A; Sinfield R; Welch J; Vora A
J Pediatr Hematol Oncol; 2005 Feb; 27(2):67-72. PubMed ID: 15701979
[TBL] [Abstract][Full Text] [Related]
39. Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia.
Gameiro P; Moreira I; Yetgin S; Papaioannou M; Potter MN; Prentice HG; Hoffbrand AV; Foroni L
Br J Haematol; 2002 Dec; 119(3):685-96. PubMed ID: 12437645
[TBL] [Abstract][Full Text] [Related]
40. Mercaptopurine in childhood leukaemia: the effects of dose escalation on thioguanine nucleotide metabolites.
Lennard L; Welch J; Lilleyman JS
Br J Clin Pharmacol; 1996 Oct; 42(4):525-7. PubMed ID: 8904630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
